RxDoctor Payments Data

McKay Moline, MD

Otolaryngology · Grand Junction, CONPI 1801277843

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,679 of the $4,057 with a category attached, or 66.0%. Inspire Medical Systems, Inc. accounts for 69.6% of it on its own, with 17 other manufacturers making up the rest.

$4,057in general payments, 2019–2025

Across 88 payments — averaging $46.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Sanofi$270
  • GSK$140
  • Tactile Systems Technology Inc$121
  • Aerin Medical Inc.$97
  • Regeneron Healthcare Solutions, Inc.$93
  • plus $513 from 12 others
$67,155in research payments, 2019–2025

Across 4 payments — averaging $16,789 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$67K

What the payments were for

  • Travel & lodging$1,37834%
  • Food & beverage$2,67966%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,057 in reported general payments places this provider in the 85th percentile of 174 otolaryngology providers in Colorado.

See all otolaryngology providers in Colorado

Medicare billing

Part B allowed, 2024
$138,377
Medicare patients
354
Services billed
1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl109$3,056
Ipratropium Bromide29$829
Nortriptyline Hcl32$541
Fluticasone Propionate19$246
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$194
Levothyroxine Sodium13$122
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$105

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Grand Junction

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →